Felix Kratz Selected Research

Felix Kratz Research Topics

Disease

41	Neoplasms (Cancer) 01/2021 - 12/2002
11	Breast Neoplasms (Breast Cancer) 09/2014 - 06/2007
10	Carcinoma (Carcinomatosis) 12/2010 - 10/2005
7	Hepatocellular Carcinoma (Hepatoma) 02/2017 - 06/2004
5	Sarcoma (Soft Tissue Sarcoma) 09/2014 - 06/2007
3	Hyperthermia 10/2012 - 02/2012
3	Cardiotoxicity 07/2012 - 02/2007
3	Prostatic Neoplasms (Prostate Cancer) 12/2010 - 03/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 09/2014 - 07/2012
2	Neoplasm Metastasis (Metastasis) 09/2012 - 12/2010
2	Lung Neoplasms (Lung Cancer) 09/2012 - 06/2006
2	Rheumatoid Arthritis 07/2012 - 01/2012
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2007 - 06/2007
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2014
1	Body Weight Changes 01/2013
1	Body Weight (Weight, Body) 01/2013
1	Hepatitis 07/2012
1	Communicable Diseases (Infectious Diseases) 01/2012
1	Brain Neoplasms (Brain Tumor) 01/2012
1	Stomach Neoplasms (Stomach Cancer) 01/2012
1	Mast Cell Activation Disorders (Mast-Cell Disease) 01/2011

Drug/Important Bio-Agent (IBA)

34	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 12/2002
26	ProdrugsIBA 01/2019 - 12/2002
22	AlbuminsIBA 06/2019 - 07/2002
12	AcidsIBA 01/2019 - 12/2002
8	Human Serum Albumin FDA LinkGeneric 09/2014 - 06/2004
7	Peptides (Polypeptides)IBA 01/2012 - 09/2003
6	DOXO-EMCHIBA 09/2014 - 02/2007
6	Paclitaxel (Taxol)FDA LinkGeneric 09/2014 - 12/2010
6	Antineoplastic Agents (Antineoplastics)IBA 07/2012 - 12/2004
5	PolymersIBA 11/2017 - 06/2006
5	Proteins (Proteins, Gene)FDA Link 08/2014 - 11/2008
5	Cathepsin BIBA 09/2012 - 05/2007
4	Albumin-Bound Paclitaxel FDA Link 09/2014 - 12/2008
4	HydrazonesIBA 02/2012 - 09/2003
4	Prostate-Specific Antigen (Semenogelase)IBA 12/2010 - 10/2005
3	Elastin-Like PolypeptidesIBA 01/2021 - 07/2012
3	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 07/2003
3	Drug CarriersIBA 01/2019 - 10/2009
3	LigandsIBA 08/2014 - 01/2008
3	Folic Acid (Vitamin M)FDA LinkGeneric 08/2014 - 11/2008
3	Sulfhydryl Compounds (Thiols)IBA 03/2008 - 12/2002
3	Peptide Hydrolases (Proteases)FDA Link 08/2007 - 10/2006
3	Asialoglycoprotein ReceptorIBA 08/2006 - 06/2004
2	EnzymesIBA 01/2021 - 01/2008
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021 - 10/2012
2	IntegrinsIBA 11/2017 - 07/2008
2	polyglycerolIBA 08/2013 - 05/2011
2	Cytostatic AgentsIBA 12/2012 - 08/2007
2	CamptothecinIBA 07/2012 - 05/2007
2	LuciferasesIBA 12/2010 - 03/2008
2	Serine Proteases (Serine Protease)IBA 03/2008 - 10/2005
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2007 - 05/2007
2	alanylphenylalanine (Ala-Phe)IBA 11/2007 - 08/2007
2	arginylarginine (Arg-Arg)IBA 11/2007 - 10/2006
2	AnthracyclinesIBA 08/2007 - 06/2007
2	Methotrexate (Mexate)FDA LinkGeneric 08/2007 - 07/2002
2	Daunorubicin (Cerubidine)FDA LinkGeneric 06/2006 - 09/2003
1	auristatinIBA 01/2019
1	Prostaglandins AIBA 11/2017
1	Sorafenib (BAY 43-9006)FDA Link 02/2017
1	Oxidoreductases (Dehydrogenase)IBA 08/2014
1	Pyruvic Acid (Pyruvate)IBA 08/2014
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 08/2014
1	NanogelsIBA 01/2014
1	Single-Chain AntibodiesIBA 08/2013
1	ErbB Receptors (EGF Receptor)IBA 08/2013
1	Immunoconjugates (Immunoconjugate)IBA 08/2013
1	Cell-Penetrating PeptidesIBA 10/2012
1	ApatitesIBA 09/2012
1	Diphosphonates (Bisphosphonates)IBA 09/2012
1	Durapatite (Hydroxylapatite)IBA 09/2012
1	Carrier Proteins (Binding Protein)IBA 07/2012
1	Ethanol (Ethyl Alcohol)IBA 07/2012
1	Transferrin (beta 2 Transferrin)IBA 07/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2012
1	cremophorIBA 07/2012
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 07/2012
1	Proteasome InhibitorsIBA 07/2012
1	thiazolyl blueIBA 07/2012
1	Exenatide (Byetta)FDA Link 01/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2012
1	technetium Tc 99m nanocolloidIBA 01/2012
1	Insulin (Novolin)FDA Link 01/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2012
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2012
1	Liraglutide FDA Link 01/2012
1	Insulin Detemir (Levemir)FDA Link 01/2012
1	anti-IgE antibodiesIBA 01/2011
1	Omalizumab (Xolair)FDA Link 01/2011
1	Monoclonal AntibodiesIBA 01/2011
1	Taxoids (Taxanes)IBA 12/2010
1	tyrosyltyrosine (Tyr-Tyr)IBA 08/2010
1	4-azidobenzylcarazolol (pABC)IBA 08/2010
1	Integrin beta3 (GPIIIa)IBA 02/2009
1	Cyclic PeptidesIBA 02/2009

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 01/2021 - 12/2002
7	Therapeutics 11/2017 - 09/2003
3	Intravenous Administration 03/2008 - 12/2002
1	Induced Hyperthermia (Thermotherapy) 07/2012